Biotechnology Stocks I Performance Guide: ACADIA Pharmaceuticals Inc. (ACAD)
ACAD has no dividends.
Table and Chart of ACAD Performance
See what a $1,000 investment in ACAD is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ACAD Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $20.65 |
| End Date | May-07-2024 |
| End Price | $17.25 |
| # Prices | 121 |
| Min Date | Jun-30-2022 |
| Min Price | $14.09 |
| Max Date | Nov-30-2020 |
| Max Price | $56.66 |
| Total Return | -16.46% |
| Annualized Return | -1.77% |
| Current Value of $1,000 Purchase | $835 |
| Number Returns | 7,260 |
| Average Return | -1.87% |
| Number Profitable Returns | 2,858 |
| Percent Profitable Returns | 39.37% |
| Number Unprofitable Returns | 4,402 |
| Percent Unprofitable Returns | 60.63% |
| Profitable to Unprofitable Returns Ratio | 0.65 |
| ACAD Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,808,451,000 |
| Beta | 0.391 | Price to Sales | 3.89 |
| Earnings per Share | $-0.3700 |
| PE Ratio | None |
| PE to Growth Ratio | -0.42 |
| Price to Book | 6.54 |
| PRICE DATA | |
| 52 Week High | $33.99 |
| 52 Week Low | $16.16 |
| Analyst Target Price | $28.96 |
| 50-Day Moving Average | $19.28 |
| 200-Day Moving Average | $24.15 |
| FINANCIAL DATA | |
| Revenue per Share | $4.434 |
| Revenue | $726,437,000 |
| Profit Margin | -8.44% |
| Return on Equity | -14.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ACAD Compare Returns with S&P 500
ACAD Trendline Chart
ACAD Moving Average Chart
ACAD Stock Return Map - See Patterns of Gains and Losses
ACAD Stock Returns/Purchase Dates